Who
Christine A. Poon
Director
Company insider
Files Form 4 as: Director, Prudential Financial; Director, Neurocrine Biosciences; Director, Regeneron Pharmaceuticals; Director, Sherwin-Williams; Director, Decibel Therapeutics; Vice Chairman, Johnson & Johnson.
In numbers
- Trades disclosed
- 456
- Buys
- 3
- Sells
- 7
- Bought
- $339K
- Sold
- $70.6M
- Companies
- 6
- Companies where not an officer
- 5
- First trade
- 30 Dec 2005
- Last trade
- 10 Sep 2026
- Last filed
- 14 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 14 Sep 2026 | PRU Prudential Financialoption or derivative · Insurance | SEC FORM 4 Code A | $19K161 at $118.48 | filing |
| 10 Sep 2026filed 14 Sep 2026 | PRU Prudential Financialoption or derivative · Insurance | SEC FORM 4 Code A | $5,80649 at $118.48 | filing |
| 10 Sep 2026filed 14 Sep 2026 | PRU Prudential Financialoption or derivative · Insurance | SEC FORM 4 Code A | $2,48821 at $118.48 | filing |
| 10 Sep 2026filed 14 Sep 2026 | PRU Prudential Financialoption or derivative · Insurance | SEC FORM 4 Code A | $19K161 at $118.48 | filing |
| 10 Sep 2026filed 14 Sep 2026 | PRU Prudential Financialoption or derivative · Insurance | SEC FORM 4 Code A | $5,80649 at $118.48 | filing |
| 10 Sep 2026filed 14 Sep 2026 | PRU Prudential Financialoption or derivative · Insurance | SEC FORM 4 Code A | $2,48821 at $118.48 | filing |
| 11 Jun 2026filed 15 Jun 2026 | PRU Prudential Financialoption or derivative · Insurance | SEC FORM 4 Code A | $19K177 at $106.51 | filing |
| 11 Jun 2026filed 15 Jun 2026 | PRU Prudential Financialoption or derivative · Insurance | SEC FORM 4 Code A | $5,75254 at $106.51 | filing |
| 11 Jun 2026filed 15 Jun 2026 | PRU Prudential Financialoption or derivative · Insurance | SEC FORM 4 Code A | $2,45023 at $106.51 | filing |
| 11 Jun 2026filed 15 Jun 2026 | PRU Prudential Financialoption or derivative · Insurance | SEC FORM 4 Code A | $19K177 at $106.51 | filing |
| 11 Jun 2026filed 15 Jun 2026 | PRU Prudential Financialoption or derivative · Insurance | SEC FORM 4 Code A | $5,75254 at $106.51 | filing |
| 11 Jun 2026filed 15 Jun 2026 | PRU Prudential Financialoption or derivative · Insurance | SEC FORM 4 Code A | $2,45023 at $106.51 | filing |
| 27 May 2026filed 29 May 2026 | NBIX Neurocrine Biosciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —2,567 at $0.00 | filing |
| 27 May 2026filed 29 May 2026 | NBIX Neurocrine Biosciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —2,567 at $0.00 | filing |
| 21 May 2026filed 21 May 2026 | NBIX Neurocrine BiosciencesPharmaceuticals | SEC FORM 4 Code M | —3,318 at $0.00 | filing |
| 21 May 2026filed 21 May 2026 | NBIX Neurocrine Biosciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —3,318 at $0.00 | filing |
| 21 May 2026filed 21 May 2026 | NBIX Neurocrine Biosciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —3,318 at $0.00 | filing |
| 21 May 2026filed 21 May 2026 | NBIX Neurocrine BiosciencesPharmaceuticals | SEC FORM 4 Code M | —3,318 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | PRU Prudential FinancialInsurance | SEC FORM 4 Code M | —1,765 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | PRU Prudential FinancialInsurance | SEC FORM 4 Code D | $181K1,765 at $102.58 | filing |
News
1,598 Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Perpetual LtdREGN · dailypolitical.com · 15 Oct 2026Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Up 3.6% – Here's What HappenedREGN · dailypolitical.com · 14 Oct 2026Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $780.00REGN · dailypolitical.com · 10 Oct 2026
0 headlines in the last 90 days name Christine A. Poon; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.